Chugai Pharmaceutical Co., Ltd. (ADR)

General ticker "CHGCY" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - General
  • Capitalization: $78.1B (TTM average)

Chugai Pharmaceutical Co., Ltd. (ADR) does not follow the US Stock Market performance with the rate: -0.6%.

Estimated limits based on current volatility of 3.3%: low 25.61$, high 27.36$

Factors to consider:

  • Company pays dividends (irregularly): last record date 2025-06-30, amount 0.41$ (Y1.52%)
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [16.97$, 25.15$]
  • 2025-12-31 to 2026-12-31 estimated range: [16.87$, 25.34$]

Financial Metrics affecting the CHGCY estimates:

  • Positive: with PPE of 28.4 at the end of fiscal year the price was neutral
  • Positive: Operating profit margin, % of 46.30 > 18.64
  • Positive: Shareholder equity ratio, % of 86.10 > 63.39
  • Negative: Investing cash flow per share per price, % of -2.02 <= -0.66
  • Negative: Operating cash flow per share per price, % of 3.97 <= 6.82

Similar symbols

Short-term CHGCY quotes

Long-term CHGCY plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue ¥1,259,946.00MM ¥1,111,367.00MM ¥1,170,611.00MM
Operating Expenses ¥726,637.00MM ¥672,193.00MM ¥628,609.00MM
Operating Income ¥533,309.00MM ¥439,174.00MM ¥542,002.00MM
Non-Operating Income ¥-2,143.00MM ¥4,647.00MM ¥1,032.00MM
Interest Expense ¥61.00MM ¥0.00MM ¥0.00MM
R&D Expense ¥149,626.00MM ¥174,868.00MM ¥181,440.00MM
Income(Loss) ¥531,166.00MM ¥443,821.00MM ¥543,034.00MM
Taxes ¥156,737.00MM ¥118,349.00MM ¥155,717.00MM
Profit(Loss)* ¥172,983.00MM ¥325,472.00MM ¥185,088.00MM
Stockholders Equity ¥1,424,387.00MM ¥1,625,580.00MM ¥1,901,499.00MM
Inventory ¥292,206.00MM ¥273,480.00MM ¥240,067.00MM
Assets ¥1,869,758.00MM ¥1,932,547.00MM ¥2,208,373.00MM
Operating Cash Flow ¥244,112.00MM ¥409,925.00MM ¥447,600.00MM
Capital expenditure ¥71,239.00MM ¥74,258.00MM ¥54,899.00MM
Investing Cash Flow ¥-145,994.00MM ¥-37,290.00MM ¥-227,365.00MM
Financing Cash Flow ¥-145,641.00MM ¥-139,331.00MM ¥-141,006.00MM
Earnings Per Share** ¥52.58 ¥98.90 ¥56.24
Ordinary share to ADR 1.00x 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.